Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03626922
Title Study of Pembrolizumab With Pemetrexed and Oxaliplatin in Chemo-Refractory Metastatic Colorectal Cancer Patients
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements No
Sponsors NSABP Foundation Inc
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UF Health Davis Cancer Pavilion & Shands Medical Plaza Gainesville Florida 32608 United States Details
Cancer Care Specialists of Central Illinois Decatur Illinois 62526 United States Details
Decatur Memorial Hospital Decatur Illinois 62526 United States Details
Crossroads Cancer Center Effingham Illinois 62401 United States Details
Cancer Care Specialists of Central IL-Swansea Swansea Illinois 062226 United States Details
University of Michigan-Oncology Ann Arbor Michigan 48109 United States Details
University of Michigan Ann Arbor Michigan 48109 United States Details
University of Michigan-Brighton Center for Specialty Care Brighton Michigan 48116 United States Details
Minnesota Oncology-Minneapolis Minneapolis Minnesota 55404 United States Details
Hennepin County Medical Center Minneapolis Minnesota 55415 United States Details
HealthPartners Riverside Clinic Minneapolis Minnesota 55454 United States Details
Hubert H. Humphrey Cancer Center Robbinsdale Minnesota 55422 United States Details
Metro Minnesota Community Oncology Research Consortium-MMCORC Saint Louis Park Minnesota 55416 United States Details
Thomas Jefferson University Hospital-Sidney Kimmel Cancer Network Philadelphia Pennsylvania 19107 United States Details
UPMC Hillman Cancer Center Pittsburgh Pennsylvania 15232 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field